Christine Gorglione, MS, CCC-SLP is a
Speech-language Pathologist based in Briarcliff, New York. Christine Gorglione is licensed to practice in New York (license number 019038) and her current practice location is
1177 Pleasantville Rd, Briarcliff, New York. She can be reached at her office (for appointments etc.) via phone at
(914) 245-0211.
NPI number for Christine Gorglione is 1699919464 and her current mailing address is 142 Valley Forge Pl, Orangeburg, New York. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1699919464.
Healthcare Provider's Profile
Full Name | Christine Gorglione |
---|
Gender | Female |
---|
Speciality | Speech-language Pathologist |
---|
Location | 1177 Pleasantville Rd, Briarcliff, New York |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1699919464
- Provider Enumeration Date: 04/23/2009
- Last Update Date: 04/23/2009
Medical Identifiers
Medical identifiers for Christine Gorglione such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1699919464 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | 019038 (New York) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christine Gorglione is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Christine Gorglione, MS, CCC-SLP 142 Valley Forge Pl, Orangeburg, NY 10962-2718 Ph: (845) 359-1016 | Christine Gorglione, MS, CCC-SLP 1177 Pleasantville Rd, Briarcliff, NY 10510-1603 Ph: (914) 245-0211 |
Reviews and Comments